Research ArticleNeuroscience Open Access | 10.1172/jci.insight.181005
1Department of Anesthesiology and
2Neuroscience Graduate Program, University of Virginia Health System, Charlottesville, Virginia, USA.
3Division of Neurology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Address correspondence to: Manoj K. Patel, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, Virginia 22908, USA. Email: mkp5u@uvahealth.org.
Find articles by Miralles, R. in: JCI | PubMed | Google Scholar
1Department of Anesthesiology and
2Neuroscience Graduate Program, University of Virginia Health System, Charlottesville, Virginia, USA.
3Division of Neurology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Address correspondence to: Manoj K. Patel, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, Virginia 22908, USA. Email: mkp5u@uvahealth.org.
Find articles by Boscia, A. in: JCI | PubMed | Google Scholar
1Department of Anesthesiology and
2Neuroscience Graduate Program, University of Virginia Health System, Charlottesville, Virginia, USA.
3Division of Neurology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Address correspondence to: Manoj K. Patel, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, Virginia 22908, USA. Email: mkp5u@uvahealth.org.
Find articles by Kittur, S. in: JCI | PubMed | Google Scholar
1Department of Anesthesiology and
2Neuroscience Graduate Program, University of Virginia Health System, Charlottesville, Virginia, USA.
3Division of Neurology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Address correspondence to: Manoj K. Patel, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, Virginia 22908, USA. Email: mkp5u@uvahealth.org.
Find articles by Hanflink, J. in: JCI | PubMed | Google Scholar
1Department of Anesthesiology and
2Neuroscience Graduate Program, University of Virginia Health System, Charlottesville, Virginia, USA.
3Division of Neurology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Address correspondence to: Manoj K. Patel, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, Virginia 22908, USA. Email: mkp5u@uvahealth.org.
Find articles by Panchal, P. in: JCI | PubMed | Google Scholar
1Department of Anesthesiology and
2Neuroscience Graduate Program, University of Virginia Health System, Charlottesville, Virginia, USA.
3Division of Neurology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Address correspondence to: Manoj K. Patel, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, Virginia 22908, USA. Email: mkp5u@uvahealth.org.
Find articles by Yorek, M. in: JCI | PubMed | Google Scholar
1Department of Anesthesiology and
2Neuroscience Graduate Program, University of Virginia Health System, Charlottesville, Virginia, USA.
3Division of Neurology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Address correspondence to: Manoj K. Patel, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, Virginia 22908, USA. Email: mkp5u@uvahealth.org.
Find articles by Deutsch, T. in: JCI | PubMed | Google Scholar
1Department of Anesthesiology and
2Neuroscience Graduate Program, University of Virginia Health System, Charlottesville, Virginia, USA.
3Division of Neurology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Address correspondence to: Manoj K. Patel, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, Virginia 22908, USA. Email: mkp5u@uvahealth.org.
Find articles by Reever, C. in: JCI | PubMed | Google Scholar
1Department of Anesthesiology and
2Neuroscience Graduate Program, University of Virginia Health System, Charlottesville, Virginia, USA.
3Division of Neurology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Address correspondence to: Manoj K. Patel, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, Virginia 22908, USA. Email: mkp5u@uvahealth.org.
Find articles by Vundela, S. in: JCI | PubMed | Google Scholar
1Department of Anesthesiology and
2Neuroscience Graduate Program, University of Virginia Health System, Charlottesville, Virginia, USA.
3Division of Neurology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Address correspondence to: Manoj K. Patel, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, Virginia 22908, USA. Email: mkp5u@uvahealth.org.
Find articles by Wengert, E. in: JCI | PubMed | Google Scholar
1Department of Anesthesiology and
2Neuroscience Graduate Program, University of Virginia Health System, Charlottesville, Virginia, USA.
3Division of Neurology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Address correspondence to: Manoj K. Patel, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, Virginia 22908, USA. Email: mkp5u@uvahealth.org.
Find articles by Patel, M. in: JCI | PubMed | Google Scholar
Published October 22, 2024 - More info
SCN8A developmental and epileptic encephalopathy (DEE) is a severe epilepsy syndrome resulting from mutations in the voltage-gated sodium channel Nav1.6, encoded by the gene SCN8A. Nav1.6 is expressed in excitatory and inhibitory neurons, yet previous studies primarily focus on how SCN8A mutations affect excitatory neurons, with limited studies on the importance of inhibitory interneurons. Parvalbumin (PV) interneurons are a prominent inhibitory interneuron subtype that expresses Nav1.6. To assess PV interneuron function within SCN8A DEE, we used 2 mouse models harboring patient-derived SCN8A gain-of-function variants, Scn8aD/+, where the SCN8A variant N1768D is expressed globally, and Scn8aW/+-PV, where the SCN8A variant R1872W is selectively expressed in PV interneurons. Expression of the R1872W SCN8A variant selectively in PV interneurons led to development of spontaneous seizures and seizure-induced death. Electrophysiology studies showed that Scn8aD/+ and Scn8aW/+-PV interneurons were susceptible to depolarization block and exhibited increased persistent sodium current. Evaluation of synaptic connections between PV interneurons and pyramidal cells showed synaptic transmission deficits in Scn8aD/+ and Scn8aW/+-PV interneurons. Together, our findings indicate that PV interneuron failure via depolarization block along with inhibitory synaptic impairment likely elicits an overall inhibitory reduction in SCN8A DEE, leading to unchecked excitation and ultimately resulting in seizures and seizure-induced death.
SCN8A developmental and epileptic encephalopathy (DEE) is a genetic epilepsy syndrome characterized by treatment-resistant seizures, developmental delay, cognitive dysfunction, and an increased incidence of sudden unexpected death in epilepsy (SUDEP) (1–4). It is caused by de novo gain-of-function (GOF) mutations in the SCN8A gene (5), which encodes the sodium channel Nav1.6 (6). Nav1.6 is expressed widely in the central nervous system and is prominent at the axon initial segment (AIS) of both excitatory and inhibitory neurons (7–9). Previous studies using mouse models of SCN8A DEE show that excitatory neurons are hyperexcitable (10), whereas somatostatin inhibitory interneurons experience increased susceptibility to depolarization block, a mechanism of action potential failure (11). Despite advances in understanding the physiological mechanisms of SCN8A DEE, current treatments are often unable to control seizures and reduce the risk of SUDEP, highlighting the need to further understand the underlying network mechanisms of this disorder.
The balance of excitation and inhibition in the brain is critical in seizure generation. Inhibitory interneurons suppress the activity of their target excitatory neurons in an effort to control network dynamics and prevent any excessive excitation that may lead to seizures (12–15). Inhibitory interneurons are incredibly diverse; a recent study has identified 28 subtypes based on morphological, electrophysiological, and transcriptomic data (16). Due to their diversity, classifications of cortical inhibitory interneurons are often changing, but currently there are 5 major identified subclasses: parvalbumin (PV), somatostatin (SST), vasoactive intestinal peptide (VIP), Lamp5, and Sncg interneurons (14–18). The most numerous subtype is PV interneurons, which make up about 40% of inhibitory interneurons and provide feed-forward and feedback inhibition to networks through reliable, high-frequency firing (14, 15). PV interneurons are known to express relatively high levels of Nav1.6 compared with other inhibitory interneurons (19) and yet have been previously unstudied in the context of SCN8A DEE, significantly limiting our understanding of the seizure network in this disorder. Inhibitory interneuron dysfunction has been heavily implicated in Dravet syndrome, another sodium channelopathy resulting from mutations in the SCN1A gene. Previous studies of Dravet syndrome indicate that PV interneurons are hypoexcitable during a critical developmental time window (20, 21). In adult mice, PV interneurons show deficits in synaptic transmission and synchronization that likely contribute to the chronic phenotype of Dravet syndrome (22, 23). Additionally, PV interneurons have also been implicated in temporal lobe epilepsy (TLE). In mouse models of TLE, previous studies show a reduction in PV staining, indicating a potential loss of PV interneurons (24, 25), and others suggest a role for PV interneurons in abnormal synapse formation (26, 27).
In this study, we used 2 mouse models of SCN8A DEE harboring the N1768D (Scn8aD/+) and R1872W (Scn8aW/+) patient-derived SCN8A variants. These models recapitulate key features of the disease through spontaneous seizures and increased risk of seizure-induced death (28–30). Scn8aD/+ mice express a germline knockin of the N1768D variant (28, 29), whereas Scn8aW/+ mice harbor a Cre-dependent knockin of the R1872W variant (30). Previous studies have used this conditional expression model to investigate cell type–specific contributions to SCN8A DEE: selective expression of the R1872W variant in forebrain excitatory neurons leads to spontaneous seizures and premature death (30), whereas selective expression of this mutation in SST inhibitory interneurons leads to audiogenic seizures without spontaneous seizures or seizure-induced death (11).
Here, we used both the global Scn8aD/+ model and the conditional Scn8aW/+ model of SCN8A DEE to assess the phenotype of mutant PV interneurons individually and as a component of the SCN8A DEE network. We report that selective expression of the R1872W SCN8A variant in PV interneurons (Scn8aW/+-PV) is sufficient to induce spontaneous seizures and premature seizure-induced death, indicating the importance of this inhibitory subtype to SCN8A DEE as a whole. Whole-cell patch clamp electrophysiology recordings of PV interneurons demonstrated an increased susceptibility to action potential (AP) failure via depolarization block. Consequently, we also observed a decrease in spontaneous inhibition received by pyramidal cells in Scn8a mutant mice. Recordings of voltage-gated sodium currents showed an elevation of the persistent sodium current (INaP) in both models and an elevation of resurgent sodium current (INaR) in the Scn8aW/+-PV model, potentially contributing to the depolarization block phenotype. A decrease in miniature inhibitory postsynaptic currents (mIPSCs) generated in Scn8aW/+-PV pyramidal cells (PCs) was also observed, suggesting a possible synaptic deficit between PV interneuron and PCs (PV:PC pairs), and dual recordings of synaptically connected cells revealed an increase in PV:PC synaptic transmission failure as well as a prolonged synaptic latency. In summary, these data reveal a substantial and previously unappreciated impairment of PV interneurons and their synaptic connections to excitatory PCs in SCN8A DEE. Selective expression of an SCN8A variant in PV interneurons shows that these impairments are sufficient to cause seizures and SUDEP in mice, indicating the importance of this critical interneuron subtype to seizure generation and redefining our understanding of the cortical microcircuit function in this disease.
Spontaneous seizures and seizure-induced death in mice with selective expression of mutant Nav1.6 in PV interneurons. We first sought to determine if expression of a GOF SCN8A variant selectively in PV interneurons would be sufficient for the development of spontaneous seizures. We used the conditional knockin Scn8aW/+ mouse model and crossed homozygous PV-Cre mice with Scn8aW/+.tdT mice to generate Scn8aW/+-PV mice, where the R1872W SCN8A variant is expressed exclusively in PV interneurons (Figure 1A). Scn8aW/+-PV mice were implanted with EEG recording electrodes and monitored for 10 weeks. To better conceptualize the phenotype of Scn8aW/+-PV mice with reference to another SCN8A DEE model, we also implanted EEG recording electrodes in Scn8aD/+ mice, which express the N1768D SCN8A variant globally, and monitored for 6–8 weeks. Spontaneous seizures were observed in all recorded Scn8aW/+-PV mice (n = 8; Figure 1, B and D) and Scn8aD/+ mice (n = 14, Figure 1, C and E). Median seizure onset in Scn8aW/+-PV mice was approximately 10 weeks of age. In Scn8aW/+-PV mice, seizures typically consisted of a wild running phase, which was immediately followed by a tonic-clonic phase in approximately 26% of seizures (23/89). Analysis of EEG signals from both Scn8aD/+ and Scn8aW/+-PV mice revealed spike wave discharges, a distinct aspect of electrographic seizures (Figure 1, B and C), highlighting similarities between a global mutation model and a model harboring an SCN8A variant exclusively in PV interneurons. Scn8aW/+-PV mice also died prematurely compared with WT littermates, with a median survival of 16.6 weeks (Figure 1F). Electrographic and video recordings verified Scn8aW/+-PV mice that died during monitoring succumbed to seizure-induced death (n = 3; Supplemental Videos 1 and 2). Interestingly, all fatal seizures exhibited a tonic phase before death, consistent with our previous findings in SCN8A DEE mice (31). In agreement with previous studies (29), Scn8aD/+ mice also died prematurely as a result of seizure-induced death (Figure 1F and Supplemental Video 3), which was significantly accelerated compared with Scn8aW/+-PV mice (P = 0.024). Overall, these findings show that a GOF variant exclusively expressed in PV interneurons can lead to seizures and seizure-induced death and support a previously unappreciated role for PV interneurons in seizure induction and seizure-induced death in a mouse model of SCN8A DEE.
Mice expressing the patient-derived SCN8A variant R1872W exclusively in PV interneurons exhibit spontaneous seizures and seizure-induced death. (A) Breeding strategy used to produce Scn8aW/+.tdT.PV-Cre mice (Scn8aW/+-PV mice, used for both in vivo and whole-cell patch clamp experiments) and age-matched littermate controls on a C57 background. These mice express the R1872W SCN8A mutation exclusively in PV interneurons, which are fluorescently labeled with tdTomato. (B) Example EEG recording of a spontaneous seizure (shown in blue) from an adult Scn8aW/+-PV mouse. Spontaneous seizure shown here resulted in seizure-induced death (Supplemental Videos 1 and 2). Purple box highlights spike wave discharges, expanded below. (C) Example EEG recording of a spontaneous seizure (red) from an adult Scn8aD/+ mouse, which expresses the N1768D SCN8A variant globally. Purple box highlights spike wave discharges, expanded below. (D) Seizure heatmap of (n = 8) Scn8aW/+-PV mice over a period of 10 weeks. (E) Seizure heatmap of (n = 14) Scn8aD/+ mice over a period of about 8 weeks. Monitoring began at slightly varying ages, indicated by white in heatmap. (F) Survival of Scn8aW/+-PV mice (n = 25) and Scn8aD/+ mice (n = 44) is significantly reduced when compared with WT (n = 27; ****, P < 0.0001; log-rank Mantel-Cox test). Survival of Scn8aD/+ mice is decreased compared with Scn8aW/+-PV mice (*, P < 0.05, log-rank Mantel-Cox test).
Depolarization block in Scn8a mutant PV interneurons. To assess the intrinsic physiological function of Scn8a mutant PV interneurons, we performed electrophysiological recordings of fluorescently labeled PV interneurons in layer IV/V of the somatosensory cortex of adult (5 to 8 weeks) Scn8aD/+, Scn8aW/+-PV, and age-matched WT littermates (Figure 2A). To verify that fluorescently labeled cells were indeed PV positive, we used immunohistochemistry to stain for PV in WT, Scn8aD/+, and Scn8aW/+-PV mice with tdTomato as a Cre-dependent fluorescent marker driven by PV-Cre, where we found that more than 95% of cells were both PV and tdTomato positive (Supplemental Figure 1). WT littermates from both Scn8aD/+ and Scn8aW/+-PV genotypes did not exhibit any differences in firing frequencies (P = 0.656) and were pooled. Analysis of membrane and AP properties revealed that Scn8aD/+ PV interneurons had decreased downstroke velocity as well as increased AP width when compared with WT (Table 1). Using a series of depolarizing current injection steps to assess intrinsic excitability, we observed a difference in excitability (P = 0.028) between WT, Scn8aD/+, and Scn8aW/+ PV interneurons. Initially, PV interneurons expressing either Scn8a variant were hyperexcitable compared with WT littermates at lower current injection steps (<100 pA in Scn8aD/+ mice, P = 0.045, and <360 pA in Scn8aW/+-PV mice, P = 0.030). However, at higher current injection steps, both Scn8aD/+ and Scn8aW/+ PV interneurons exhibited progressive AP failure as a result of depolarization block (>640 pA in Scn8aD/+ mice, P = 0.042; >840 pA in Scn8aW/+-PV mice, P = 0.041; Figure 2, B–F). Both Scn8aD/+ and Scn8aW/+ PV interneurons were more prone to depolarization block than their WT counterparts over the range of current injection magnitudes (P < 0.0001 and P = 0.016, respectively; Figure 2F). Depolarization block of inhibitory interneurons has been previously implicated in seizure-like activity both in vitro and in vivo and has been proposed as a biophysical mechanism underlying approach of seizure threshold (32–37). Here, the early onset of depolarization block in Scn8a mutant PV interneurons indicates a PV hypoexcitability phenotype, similar to the phenotypes observed in PV interneurons in GOF SCN1A DEE and in SST interneurons in SCN8A DEE (11, 32).
Altered excitability and depolarization block in Scn8aD/+ and Scn8aW/+-PV interneurons. (A) Whole-cell recordings were collected from WT, Scn8aD/+, and Scn8aW/+-PV interneurons in layer IV/V of the somatosensory cortex in adult 5- to 8-week old mice. (B–D) Example traces of WT (B, black), Scn8aD/+ (C, red), and Scn8aW/+ (D, blue) PV interneuron firing at 200, 400, 600, and 800 pA current injections. Depolarization block is noted with arrows (DB). (E) Scn8aD/+ (n = 17 cells, 6 mice) and Scn8aW/+ PV (n = 17 cells, 5 mice) interneurons experience a decrease in firing via depolarization block (*, P < 0.05, 2-way ANOVA with Tukey’s multiple comparisons test) when compared with WT PV interneurons (n = 18 cells, 8 mice). Red or blue stars indicate individual points of significance for either Scn8aD/+ or Scn8aW/+-PV, respectively, by multiple comparisons test. (F) Cumulative distribution of PV interneuron entry into depolarization block relative to current injection magnitude for WT, Scn8aD/+, and Scn8aW/+-PV mice (****, P < 0.0001; *, P < 0.05, log-rank Mantel-Cox test).
Previous studies have shown that excitatory pyramidal neurons in global knockin Scn8aD/+ mice are hyperexcitable compared with WT, suggesting that a global change in neuronal activity of both inhibitory and excitatory neurons likely contributes to the seizure phenotype (10). To determine if firing is affected in excitatory neurons from Scn8aW/+-PV mice, which selectively express an Scn8a variant in PV interneurons, we recorded the intrinsic excitability of pyramidal neurons from cortical layers IV/V in adult mice (Supplemental Figure 2). Interestingly, we did not observe any differences in the intrinsic excitability of pyramidal neurons between the WT and Scn8aW/+-PV genotypes (Supplemental Figure 2). This suggests that alterations in the physiology of PV interneurons may be sufficient in facilitating seizures in SCN8A DEE. Analysis of AP parameters revealed an increase in input resistance and a decrease in rheobase (Supplemental Figure 2, E and F, and Supplemental Table 1), suggestive of some compensatory changes in excitatory PCs.
Additionally, the role of development is an important consideration in understanding the pathophysiology of SCN8A DEE. In Dravet syndrome, differences in PV interneuron intrinsic excitability are observed only during a critical developmental time window (P18–P21) (21). To determine if the same was true for PV interneurons in SCN8A DEE, we measured intrinsic excitability at the critical P18–P21 time window (Supplemental Figure 3). Although no differences in intrinsic excitability were observed (Supplemental Figure 3B), there were significant differences in AP waveform between WT, Scn8aD/+, and Scn8aW/+-PV interneurons at P18–P21. APs in P18–P21 Scn8a mutant mice were significantly wider, with slower upstroke and downstroke velocities, than in their WT counterparts (Supplemental Figure 3, C–F, and Supplemental Table 2). These findings indicate early alterations in PV interneuron AP parameters before the onset of spontaneous seizures and may suggest a progression of PV interneuron physiology into adulthood.
GOF Nav1.6 mutations affect sodium channel currents in PV interneurons. Depolarization block in Scn8aD/+ and Scn8aW/+ PV interneurons likely arises from abnormal sodium channel activity as a result of the GOF variant, contributing to changes in membrane depolarization levels and subsequent sodium channel availability for AP initiation. Increases in the INaP have been identified as a major factor in many epileptic encephalopathy–causing variants, including both the N1768D and R1872W variants in SCN8A DEE (5, 10, 30, 38). Further, INaP is a known determinant of depolarization block threshold (11). In view of this, we recorded INaP in PV interneurons in the whole-cell patch clamp configuration (Figure 3A). INaP was increased in both Scn8aD/+ (–293.1 ± 38.0 pA; P = 0.032) and Scn8aW/+ (–347.1 ± 49.0 pA; P = 0.004) PV interneurons when compared with WT (–166.6 ± 29.7 pA; Figure 3, B–E). Half-maximal voltage of activation (V1/2) did not differ from WT (–62.0 ± 1.0 mV) in either Scn8aD/+ (–59.9 ± 1.1 mV; P = 0.329) or Scn8aW/+-PV (–63.9 ± 1.2 mV; P = 0.592) mice (Figure 3F). Another component of the sodium current that may affect excitability particularly in fast spiking cells is the INaR (39, 40). INaR is a slow inactivating depolarizing current that can contribute to increased AP frequency by providing additional depolarization during the falling phase of an AP (39–41). INaR has been previously implicated in TLE as well as in sodium channelopathies (42, 43). INaR was significantly increased in Scn8aW/+-PV interneurons (–1,136.0 ± 178.5 pA; P = 0.037), and while we observed an increasing trend, INaR was not significantly increased in Scn8aD/+ PV interneurons (–952.8 ± 172.9 pA; P = 0.219), when compared to WT (–595.9 ± 84.8 pA) PV interneurons (Figure 3, G–J). Current-voltage relationship of INaR was not different between WT, Scn8aD/+, and Scn8aW/+-PV mice (P = 0.631; Figure 3K). These results demonstrate an increase in 2 components of the overall sodium current in PV interneurons, which possibly contributes to their initial hyperexcitability and increased susceptibility to depolarization block. Increases in both INaP and INaR probably provide a sustained level of depolarization, resulting in the accumulation of inactivated sodium channels and increased susceptibility to depolarization block (11, 32, 44).
INaP and INaR in WT, Scn8aD/+, and Scn8aW/+ PV interneurons. (A) INaP and INaR were recorded via whole-cell patch clamp onto PV interneurons in layer IV/V of the somatosensory cortex in adult, 5- to 8-week-old WT (n = 14 cells, 5 mice), Scn8aD/+ (n = 12 cells, 4 mice), and Scn8aW/+-PV mice (n = 15 cells, 5 mice). (B–D) Example traces of steady-state INaP evoked by slow voltage ramps from WT (B, black), Scn8aD/+ (C, red), and Scn8aW/+ (D, blue) PV interneurons. Traces in gray show slow voltage ramp in the presence of 500 nM tetrodotoxin (TTX). (E) Elevated maximum INaP in Scn8aD/+ (*, P < 0.05) and Scn8aW/+-PV (**, P < 0.01) interneurons compared with WT PV interneurons (Kruskal-Wallis test with Dunn’s multiple comparison test). (F) V1/2 values were not different between WT, Scn8aD/+, and Scn8aW/+-PV mice (P > 0.05, 1-way ANOVA with Dunnett’s multiple comparison test). (G–I) Example traces of TTX-subtracted INaR for WT (G, black), Scn8aD/+ (H, red), and Scn8aW/+ (I, blue). (J) Maximum INaR magnitude was increased between WT and Scn8aW/+-PV interneurons (*, P < 0.05), whereas INaR magnitude between WT and Scn8aD/+ PV interneurons was not significantly different (P > 0.05, Brown-Forsythe ANOVA with Dunnett’s multiple comparison test). (K) Current-voltage relationship for INaR is not significantly different between WT, Scn8aD/+, and Scn8aW/+-PV mice (P > 0.05, 2-way ANOVA).
Alterations of both activation and steady-state inactivation parameters of the transient sodium channel current have been previously reported in cells expressing GOF SCN8A variants (5, 45–47). To examine PV interneuron sodium channel currents, we performed excised somatic patches in the outside-out configuration from PV interneurons (Figure 4A). Sodium current density, voltage-dependent activation, or steady-state inactivation were not different between WT, Scn8aD/+, and Scn8aW/+-PV mice (Figure 4, B–H, and Table 2).
Transient sodium currents in WT, Scn8aD/+, and Scn8aW/+ PV interneurons. (A) Transient sodium current was assessed in PV interneurons using patch-clamp recordings in the outside-out configuration. (B–D) Example traces of sodium currents recorded from WT (B, black), Scn8aD/+ (C, red), and Scn8aW/+ (D, blue) PV interneurons. (E) Maximum transient sodium current was not significantly different between WT (n = 20 cells, 8 mice), Scn8aD/+ (n = 12 cells, 4 mice), and Scn8aW/+ (n = 12 cells, 4 mice) PV interneurons (P > 0.05, Kruskal-Wallis test with Dunn’s multiple comparison test). (F) Current-voltage relationship does not differ between WT, Scn8aD/+, and Scn8aW/+-PV interneurons (P > 0.05, 2-way ANOVA). (G) Voltage-dependent conductance curve does not differ significantly between WT, Scn8aD/+, and Scn8aW/+ PV interneurons (P > 0.05, 2-way ANOVA). (H) Steady-state inactivation does not differ significantly between WT (n = 12 cells, 4 mice), Scn8aD/+ (n = 11 cells, 4 mice), and Scn8aW/+ (n = 10 cells, 4 mice) PV interneurons (P > 0.05, 2-way ANOVA). Boltzmann curves shown are the average of individual curves generated from fits to data points.
Decreased inhibitory input onto excitatory neurons in Scn8a mutant mice. Impaired excitability in Scn8a mutant PV interneurons may lead to decreased inhibition onto excitatory PCs, as PV interneurons are known to directly inhibit PCs at the soma or AIS (14, 15). To examine how alterations in PV interneuron excitability affect the cortical network, we recorded sIPSCs and mIPSCs from PCs (Figure 5A) as a functional indicator of PV interneuron activity and connectivity. We found that PCs generated significantly fewer sIPSCs in both Scn8aD/+ (4.22 ± 0.64 Hz; P = 0.035) and Scn8aW/+-PV (4.07 ± 1.14 Hz; P = 0.003) mice than their WT counterparts (7.97 ± 0.88 Hz; Figure 5, B and C), suggesting a decrease in inhibitory input onto PCs. sIPSC frequencies between Scn8aD/+ and Scn8aW/+-PV PCs were not different (P > 0.99), which may imply that PV interneurons are largely responsible for the decrease in somatic inhibitory input in the global Scn8aD/+ model. sIPSC amplitude was not different between WT (–62.7 ± 4.3 pA), Scn8aD/+ (–54.7 ± 5.8 pA), and Scn8aW/+-PV mice (–53.3 ± 8.4 pA; P = 0.09, Figure 5D). Additionally, we calculated the total charge transfer from sIPSCs in WT, Scn8aD/+, and Scn8aW/+-PV PCs and found that the total spontaneous charge transfer onto PCs was significantly decreased in Scn8aW/+-PV mice (–15,346 ± 3,706 pA × s; P = 0.008) compared with WT (–41,468 ± 7,641 pA × s, Figure 5E). Although it was not statistically significant, we also observed a decreasing trend in spontaneous inhibitory charge transfer in Scn8aD/+ mice (–20,424 ± 4,895 pA × s; P = 0.08; Figure 5E). sIPSC recordings include both AP-induced synaptic transients as well as mIPSCs, which occur because of spontaneous vesicle fusion in the absence of an AP (48, 49). To isolate AP-independent events, we performed recordings in the presence of TTX (500 nM). Relative to WT controls (3.52 ± 0.65 Hz), we found no significant difference in PC mIPSC frequency in Scn8aD/+ mice (2.78 ± 0.57 Hz; P = 0.821), but we did observe a significant reduction of mIPSC frequency in Scn8aW/+-PV mice (1.43 ± 0.22 Hz; P = 0.027; Figure 5F), which could underlie impaired synaptic transmission in Scn8aW/+-PV mice. mIPSC amplitude did not differ between WT (–37.7 ± 3.7 pA), Scn8aD/+ (–41.6 ± 3.0 pA; P = 0.667), and Scn8aW/+-PV mice (–25.1 ± 3.5 pA; P = 0.055, Figure 5G), though we did observe a decreasing trend in the mIPSC amplitude for Scn8aW/+-PV mice. Interestingly, we did not observe any significant differences in mIPSC total charge transfer between WT (–6,874 ± 1,194 pA × s), Scn8aD/+ (–6,907 ± 1,426 pA × s; P = 0.984), and Scn8aW/+-PV mice (–3,734 ± 872.6 pA × s; P = 0.133, Figure 5H).
IPSCs generated in PCs from WT, Scn8aD/+, and Scn8aW/+-PV mice. (A) Whole-cell recordings of IPSCs were collected from cortical layer V PCs in adult, 5- to 8-week-old WT, Scn8aD/+, and Scn8aW/+-PV mice. (B) Example traces of IPSCs generated in PCs from WT (black), Scn8aD/+ (red), and Scn8aW/+-PV (blue) mice. (C) Frequency of sIPSCs generated in PCs is decreased in Scn8aD/+ (n = 15 cells, 4 mice, *, P < 0.05) and Scn8aW/+-PV (n = 16 cells, 5 mice, **, P < 0.01) mice when compared with WT (n = 20 cells, 6 mice, Kruskal-Wallis test with Dunn’s multiple-comparison test). (D) Amplitude of sIPSCs generated in PCs is not significantly different between groups (P > 0.05, Kruskal-Wallis test with Dunn’s multiple-comparison test). (E) Total sIPSC charge transfer onto PCs was significantly decreased in Scn8aW/+-PV mice (**, P < 0.01), whereas total sIPSC charge transfer in Scn8aD/+ mice was not significantly different (P > 0.05, Kruskal-Wallis test with Dunn’s multiple-comparison test). (F) Frequency of mIPSCs recorded from PCs is decreased in Scn8aW/+-PV (n = 8 cells, 3 mice) mice when compared with WT (n = 7 cells, 3 mice, *, P < 0.05), whereas frequency of mIPSCs recorded from PCs in Scn8aD/+ (n = 7 cells, 3 mice) mice did not significantly differ from WT (P > 0.05, 1-way ANOVA with Dunnett’s multiple-comparison test). (G) Amplitude of mIPSCs recorded from PCs is not significantly different between WT, Scn8aD/+, and Scn8aW/+-PV mice (P > 0.05, Brown-Forsythe ANOVA with Dunnett’s multiple comparison test). (H) Total mIPSC charge transfer onto PCs did not significantly differ between WT, Scn8aD/+, and Scn8aW/+-PV mice (P > 0.05, Kruskal-Wallis test with Dunn’s multiple-comparison test).
PV interneuron synaptic transmission is impaired in Scn8a mutant mice. Impairment of synaptic transmission has been suggested as a disease mechanism in multiple epilepsy syndromes, notably Dravet syndrome (23, 50, 51), and proper synaptic signaling is tightly linked to sodium channel function (52). To assess how Nav1.6 function influences PV interneuron-mediated inhibitory synaptic transmission, we performed dual whole-cell patch clamp recordings of PV interneurons and nearby PCs to find synaptically connected pairs of cells (Figure 6A). Synaptically connected pairs were identified using a current ramp in the presynaptic PV interneuron to elicit inhibitory postsynaptic potentials (IPSPs) in the postsynaptic PC corresponding to each AP in the PV interneuron (Figure 6B). The number of synaptically connected PV:PC pairs relative to the total number of pairs was not significantly different between WT, Scn8aD/+, and Scn8aW/+-PV mice (P = 0.634, Figure 6C). In PV:PC connected pairs, we measured the properties of unitary inhibitory postsynaptic currents (uIPSCs) in PCs evoked by stimulation of PV interneurons. To accurately detect uIPSCs, a high-chloride internal solution was used to allow recording of uIPSCs as large inward currents and IPSPs as large membrane depolarizations, overall minimizing the possibility of inaccurately reporting a synaptic failure.
Increased synaptic transmission failure and synaptic latency in Scn8a mutant mice. (A) Image of dual whole-cell recording of a synaptically connected PV interneuron and pyramidal cell pair. (B) Example traces from a PV interneuron (gray) and synaptically coupled pyramidal cell (PC; black). (C) Proportion of successfully patched PV:PC pairs that were synaptically connected did not differ between WT (49 pairs from 13 mice), Scn8aD/+ (40 pairs from 8 mice), and Scn8aW/+-PV (54 pairs from 9 mice) in adult mice. (D–F) Example of presynaptic firing and evoked uIPSCs in WT (D; black), Scn8aD/+ (E; red), and Scn8aW/+-PV (F; blue) connected pairs at 5 Hz, 10 Hz, 20 Hz, 40 Hz, 80 Hz, and 120 Hz. Purple arrows denote uIPSC failures in the postsynaptic neuron. (G–L) Summary data for failure rates of evoked uIPSCs at various frequencies. In Scn8aD/+ connected pairs (n = 7, 5 mice), uIPSC failure rate is not significantly different from WT (n = 4, 3 mice) at 5, 10, 20, or 40 Hz (P > 0.05, G–J) but is significantly higher at PV interneuron firing frequencies of 80 and 120 Hz (*, P < 0.05, K and L). uIPSC failure rate in Scn8aW/+-PV pairs (n = 6, 5 mice) is significantly higher than WT at 5, 10, 20, 80, and 120 Hz (*, P < 0.05, G–I, K, and L) but did not significantly differ at 40 Hz (P < 0.05, J, 1-way ANOVA with Dunnett’s multiple-comparison test). (M and N) Example traces illustrating synaptic latency in WT, Scn8aD/+, and Scn8aW/+-PV, measured from the peak of the presynaptic AP to the onset of the evoked uIPSC (M). Gray dotted lines indicate this latency in WT. Latency is increased in Scn8aD/+ and Scn8aW/+-PV mice (N, 1-way ANOVA with Dunnett’s multiple-comparison test, *, P < 0.05, **, P < 0.01).
Previous studies indicate that the PV:PC synapse is extremely reliable since PV interneurons have multiple synaptic boutons and a high release probability, indicative of a highly stable synapse (53). PV interneurons are also known to fire reliably at high frequencies (15). We found that stimulation of PV interneurons at a 1 Hz frequency reliably initiated single APs in WT mice. Although we detected some failures in Scn8aD/+ and Scn8aW/+-PV mice, there was no significant difference in synaptic failure at a frequency of 1 Hz (P = 0.160; Table 3) between the groups, suggesting no deficit in synaptic transmission at low stimulation frequencies. The amplitudes of the uIPSCs also did not differ between genotypes (Table 3, P = 0.427). Additionally, to identify any deficits in short-term synaptic plasticity, we used the first 2 IPSCs (IPSC1 and IPSC2) elicited by a presynaptic AP to quantify the paired-pulse ratio (PPR). The PV:PC synapse is known to experience short-term plasticity through synaptic depression (54, 55). We observed synaptic depression in WT, Scn8aD/+, and Scn8aW/+-PV connected pairs, with no significant difference in PPR between WT and Scn8a mutant pairs (P = 0.340 and P = 0.189 respectively; Table 3).
To analyze activity-dependent synaptic failure, we then used stimulation trains to elicit multiple APs at increasing frequencies (5, 10, 20, 40, 80, and 120 Hz; Figure 6, D–F, and Table 3). At each frequency, we measured the failure rate of the first and last uIPSC as well as the overall failure rate. Failure rate of the first uIPSC remained low and consistent between WT, Scn8aD/+, and Scn8aW/+-PV mice. At lower frequencies (≤40 Hz), there were no differences in overall failure rate or last uIPSC failure rate between WT and Scn8aD/+mice; however, failure rates were significantly increased in Scn8aW/+-PV mice at 5, 10, and 20 Hz (Figure 6, G–I), with an increasing trend at a 40 Hz stimulation frequency (Figure 6J). At 80 Hz, the overall failure rate in a 20-pulse train was increased in both Scn8aD/+ (0.316 ± 0.062; P = 0.039) and Scn8aW/+-PV (0.390 ± 0.048; P = 0.009) mice compared with WT (0.101 ± 0.040; Figure 6K), with failures occurring approximately 3 times as frequently in Scn8aW/+ mice when compared with WT. Similarly, at 120 Hz stimulation frequency with a 30-pulse train, failure rates observed in Scn8aD/+ and Scn8aW/+-PV pairs were greater (0.382 ± 0.048 and 0.412 ± 0.068, respectively; P = 0.016 and P = 0.009) than those observed in their WT counterparts (0.123 ± 0.087; Figure 6L). The progression of total activity-dependent synaptic failure through increasing presynaptic stimulation frequencies is shown in Figure 6, G–L. Additionally, synaptic failure of the last uIPSC in a stimulation train occurred in more than 40% of trials on average with a stimulation frequency of 80 or 120 Hz. We observed that this increase in synaptic failure was significant for the last uIPSC in an 80 Hz train in Scn8aD/+ (P = 0.023) and Scn8aW/+-PV (P = 0.025; Table 3), as well as in a 120 Hz train (P = 0.043 and P = 0.030, respectively), supporting a greater degree of activity-dependent failure. Analysis of synaptic latency times, measured from the peak of the presynaptic AP to the onset of the postsynaptic uIPSC, revealed an increase in synaptic latency in Scn8aD/+ (P = 0.009) and Scn8aW/+-PV (P = 0.012) mice when compared with WT mice (Figure 6, M and N, and Table 3). Prolonged synaptic latency would suggest an impairment in conduction velocity or GABA release probability, potentially with a longer time lag to vesicle release (56–59). Efficient synaptic transmission and vesicle release are critical for overall network inhibition (60).
PV interneurons prominently express Nav1.6 (8, 9) and are known to play a major role in various epilepsies (20, 23–27, 61). However, their role in the pathophysiology of SCN8A DEE is unknown. Here, we show that (a) expression of the patient-derived R1872W SCN8A GOF variant selectively in PV interneurons conveys susceptibility to spontaneous seizures and premature seizure-induced death; (b) GOF SCN8A mutations in PV interneurons lead to initial hyperexcitability and subsequent AP failure via increased susceptibility to depolarization block; (c) PV interneurons in both GOF SCN8A mouse models exhibit epileptiform increases in INaP that would facilitate increased susceptibility to depolarization block; (d) inhibitory input onto excitatory PCs is significantly reduced in Scn8a mutant mice; and (e) there is a progressive, activity-dependent increase in synaptic transmission failure from PV inhibitory interneurons onto excitatory neurons. Our findings highlight a role for PV interneurons in the pathophysiology of seizures and seizure-induced death in mouse models of SCN8A DEE.
Expression of R1872W SCN8A mutation in PV interneurons is sufficient to cause seizures and premature death. PV interneurons are known to be the main drivers for seizure activity in Dravet syndrome, a disorder characterized by deficits in inhibitory neurons, primarily due to haploinsufficiency of Nav1.1 (20–23). Selective deletion of Nav1.1 in PV interneurons leads to reduced PV interneuron excitability, decreased spontaneous inhibition of excitatory neurons, and increased susceptibility to seizures (61). Similar to impairments observed in mouse models of Dravet syndrome and in Scn8aD/+ mice, which express the N1768D SCN8A variant globally, we show here that selective expression of the GOF R1872W variant in PV interneurons is sufficient to induce spontaneous seizures and leads to seizure-induced death (SUDEP) in mice. Additionally, Scn8aW/+-PV mice exhibited a reduced seizure frequency and increased survival compared with Scn8aD/+ mice, and global expression of the R1872W variant or exclusive expression in excitatory neurons leads to a more severe SUDEP phenotype than Scn8aW/+-PV mice (30). This may indicate that although PV interneurons are an important contributor to the SCN8A DEE phenotype, dysfunction of excitatory neurons remains a critical aspect of the disease physiology, as previously published (10, 30, 62). Overall, these findings not only support an important role for PV interneurons in the seizure phenotype of SCN8A DEE but also provide support for a major role for Nav1.6 channels in controlling PV interneuron excitability in addition to Nav1.1 channels.
GOF SCN8A mutations result in premature PV interneuron depolarization block. Proper function of Scn8a is critical in repetitive firing (41), and as such, we reasoned that mutations affecting the function of Scn8a would affect the high-frequency, repetitive firing characteristic of PV interneurons. However, although at lower current injection magnitudes PV interneurons from both mutant mouse models were hyperexcitable, at higher magnitudes we observed PV interneuron AP failure through depolarization block, resulting in overall PV interneuron hypoexcitability. Increased susceptibility to depolarization block due to a GOF sodium channel mutation has been shown previously in both SCN8A DEE and SCN1A DEE (11, 32). Additionally, depolarization block in PV interneurons leads to hyperactivity and subsequent epileptic discharges in excitatory cells, and rescue of depolarization block via optogenetic stimulation leads to a reduction in epileptiform activity (34–36). Further, in vivo recording of PV interneurons shows evidence for PV depolarization block during seizure activity (37).
Interestingly, the susceptibility to depolarization block and subsequent hypoexcitability in inhibitory interneurons reported here indicates that a mechanism for seizures in SCN8A DEE, a disorder characterized primarily by GOF sodium channel mutations, shares many similarities to that of Dravet syndrome, a disorder primarily characterized by sodium channel haploinsufficiency in inhibitory neurons. A study using a model of Dravet syndrome showed a similar pattern of initial hyperexcitability in PV interneurons followed by depolarization block (63). However, impairment of PV interneuron excitability in Dravet syndrome is specific to the P18–P21 developmental time window (21), whereas in SCN8A DEE, PV interneuron activity is more markedly impaired in adulthood. The initial hyperexcitability of inhibitory interneurons seen in both SCN8A DEE and Dravet syndrome may play some role in the shared comorbidities between these severe developmental disorders.
Impaired synaptic transmission between mutant PV interneurons and PCs. We believe our study is the first to examine alterations in synaptic transmission between PV interneurons and excitatory neurons in SCN8A DEE, and we show a distinct impairment of inhibitory synaptic transmission onto excitatory PCs in 2 patient-derived mutation models. Synaptic transmission was impaired in both Scn8a mutant mouse models: Scn8aW/+-PV connected pairs failed substantially more than WT at most frequencies, whereas Scn8aD/+ pairs failed in an activity-dependent manner. Considering the fast-spiking nature of PV interneurons and the degree of inhibitory input they provide on neuronal excitatory networks, activity-dependent failure alone could have a substantial impact on overall seizure susceptibility. A likely mechanism for this failure could be impaired AP propagation, as proper signaling from PV interneurons requires a specific density and function of sodium channels (52). This is further supported by the observed increase in synaptic latency, indicating that propagation may be slowed in Scn8a mutant mice. Similarly, synaptic transmission between PV interneurons and PCs is also impaired in Dravet syndrome, though unlike our findings in SCN8A DEE, intrinsic excitability deficits are restored in adult PV interneurons (21, 23). A limitation of the study is the number of synaptically connected pairs recorded. It is possible that synaptic transmission is impaired in a non-activity-dependent manner in both Scn8aD/+ and Scn8aW/+-PV mice, as a slight increasing trend in the failure rates of Scn8aD/+ uIPSCs at low frequencies was observed.
Both depolarization block and synaptic transmission failure occurred at high PV interneuron firing frequencies, and as such, it is important to consider in vivo firing frequencies of PV interneurons. PV interneurons are a heterogeneous group made up of primarily basket cells and chandelier cells, which are named for their unique morphologies. These subtypes have slightly different firing patterns and synaptic targets (14, 15). Since our recordings are focused within cortical layers IV/V, it is likely that we recorded primarily from PV-positive basket cells rather than chandelier cells. In vivo, PV interneurons, particularly basket cells, are phase-locked to gamma oscillations, which typically occur between 40 and 100 Hz (64). Events such as sharp wave ripples (SWRs) can lead to PV firing frequencies of more than 120 Hz in vivo (65). This demonstrates the relevance of both increased susceptibility of PV interneurons to depolarization block and of PV:PC synaptic transmission failure at high frequencies with expression of mutant Scn8a. These gamma oscillations and SWRs are most often associated with the hippocampus; however, there is evidence for oscillations in the cortex (66, 67). Recently, SWRs have been associated with epileptic discharges in Dravet syndrome: an increase in SWR amplitude may lead to inhibitory depolarization block and a shift into seizure-like activity (68). Considering the frequencies at which we observe PV interneuron failure in both Scn8a mutant mouse models, increased susceptibility to depolarization block and failure of inhibitory synaptic transmission could underlie an additional mechanism of seizure generation in SCN8A DEE.
Elevated sodium currents in Scn8a mutant PV interneurons. We observed an increase in INaP in both Scn8aD/+ and Scn8aW/+-PV interneurons with an increase in INaR in Scn8aW/+-PV interneurons. However, we observed no difference in the transient sodium current in Scn8aD/+ and Scn8aW/+-PV interneurons, though it is possible that excised somatic patches may not have recapitulated the high levels of Nav1.6 in the axon. Previous studies suggest that Scn8a may have a much larger role in INaR than transient current (41). Increases in INaP have been implicated in various epilepsies (38, 42, 44, 69), and prior computational modeling suggests that heightened INaP underlies the phenotype of increased susceptibility to depolarization block in inhibitory interneurons (11). INaP also functions as an amplifier of synaptic currents (70, 71), although we did not observe differences in amplitude of uIPSCs in recordings of synaptically connected pairs. Because INaP is a consistent, non-inactivating component of the sodium current (44), we hypothesize that elevations in INaP contribute to premature failure of PV interneurons and subsequent entry into depolarization block. Additionally, INaR currents are crucial in facilitating repetitive, high-frequency firing, as they affect fast inactivation through an open channel block (40, 72), and Nav1.6 is a crucial contributor to INaR (41). We only observed a significant increase in INaR in Scn8aW/+-PV interneurons and not in Scn8aD/+ PV interneurons, possibly due to mutation-specific effects: this has been observed previously in patient-derived neurons (73). Increases in INaR likely provide excessive depolarizing current resulting in an increase in firing frequencies, which may be responsible for differences observed between Scn8aD/+ and Scn8aW/+-PV interneuron firing, as Scn8aD/+ PV interneurons enter depolarization block at lower current injections.
It is also important to consider the potential consequences of a GOF Nav1.6 mutation on the structural composition of the AIS. Sodium channels are expressed together with potassium channels at the AIS, and both play crucial roles in controlling neuronal excitability (8). Further, previous studies suggest interaction between sodium and potassium channels as a result of genetic mutations (74–76). Potassium channels such as Kv7.2, which is encoded by KNCQ2, interacts with Nav1.6, and is an important mediator of M-type potassium current (77, 78), or Kv3.1, which is important for repetitive, high-frequency firing (79), could be affected by these changes in sodium channel function and may underlie some physiological differences observed in Scn8a mutant PV interneurons. Interaction between Scn8a and Kcnq2 has been shown previously in a DEE model: in DEE resulting from loss-of-function mutations in Kcnq2, an antisense oligonucleotide (ASO) to reduce the expression of Scn8a leads to a marked increase in survival (75).
Implications for SCN8A DEE. Patients with SCN8A variants are typically treated with sodium channel blockers, and many are refractory to treatment, highlighting the need to further understand the basic mechanisms surrounding the SCN8A DEE phenotype. Hyperexcitability of excitatory neurons has often been suggested as the underlying cause behind seizures in SCN8A DEE, and, contradictory to our results here, a previous study suggests limited involvement of inhibitory interneurons due to the lack of seizures when the R1872W SCN8A variant is expressed in all inhibitory interneurons (30). However, in the previous study, the SUDEP phenotype of mice expressing the R1872W variant globally (Scn8aW/+; EIIa-Cre) is markedly more severe than that of mice expressing the R1872W variant exclusively in forebrain excitatory neurons (Scn8aW/+; EMX1-Cre), with median survival of 15 days and 46 days, respectively (30), suggesting the involvement of additional cell types. While we acknowledge the critical contributions of excitatory neuron dysfunction to the SCN8A DEE phenotype (10, 30, 62), here we provide compelling support for a major involvement of PV inhibitory interneurons in the onset of spontaneous seizures and seizure-induced death in SCN8A DEE.
Gene therapies are in development for both SCN8A DEE and Dravet syndrome, and downregulation of Scn8a has been shown to reduce seizures in both disorders (80–82). Specifically, an ASO for Scn8a was able to significantly delay seizure onset and increase survival in mice that express the R1872W SCN8A variant globally (80). This ASO treatment targeted both excitatory and inhibitory neurons. Our previous studies have shown that ASO-mediated rescue of PV interneuron firing reduces seizures and prevents SUDEP in a model of Dravet syndrome (82); a similar phenotype may be observed in SCN8A DEE, where rescue of depolarization block prevents seizures and SUDEP. In a similar manner to Dravet syndrome, specific targeting of inhibitory interneurons in SCN8A DEE may be a novel therapeutic strategy.
In conclusion, we show here that PV interneurons play an important role in SCN8A DEE. Elevations in INaP likely render PV interneurons more susceptible to AP failure, and subsequent depolarization block leads to a decrease in network inhibition. PV interneurons also exhibit impaired synaptic transmission, and together, we observe that a GOF SCN8A variant exclusively expressed in PV interneurons conveys susceptibility to spontaneous seizures and SUDEP. In the field of SCN8A DEE, prior research has focused primarily on the impact of GOF SCN8A mutations on excitatory neurons (10, 30, 62). These results, along with our previous work proposing that SST interneurons contribute to seizures (11), shift the paradigm of the SCN8A DEE field from primarily considering excitatory neuron hyperexcitability as the sole driver of the seizure phenotype and call for future studies to further explore the importance of inhibitory neuron activity in SCN8A DEE.
Sex as a biological variable. Both male and female mice were used in this study. While roughly equal numbers of each sex were used in each experimental group, sex was not considered as a biological variable.
Mouse husbandry and genotyping. Scn8aD/+ and Scn8aW/+ mice were generated as previously described and maintained through crosses with C57BL/6J mice (The Jackson Laboratory [Jax], 000664) to keep all experimental mice on a C57BL/6J genetic background (29, 30). Both Scn8aD/+ and Scn8aW/+ transgenic mice were previously gifted from Miriam Meisler at the University of Michigan, Ann Arbor, Michigan, USA. Cell type–specific expression of R1872W was achieved using males heterozygous for the R1872W allele and C57BL/6J females homozygous for PV-Cre (Jax, 017320) to generate mutant mice (Scn8aW/+-PV) (30). Homozygous PV-IRES-Cre females were used for breeding to ensure minimal germline recombination due to Cre, as shown previously (83, 84). Because certain transgenic mice entail the insertion of Cre directly into the coding sequence and because of the need for a fluorescent reporter to reliably identify PV interneurons in-slice, for all experiments we used WT controls that contained the same Cre allele but lacked the allele encoding the Scn8a variant. Fluorescent labeling of PV interneurons was achieved by first crossing Scn8aD/+ or Scn8aW/+ mice with C57BL/6J mice homozygous for a Cre-dependent tdTomato reporter (Jax, 007909) to generate Scn8aD/+ tdTomato or Scn8aW/+ tdTomato mice. Then, male Scn8aD/+ tdTomato or Scn8aW/+ tdTomato mice were crossed with female mice homozygous for PV-Cre. Experimental groups used at least 3 randomly selected mice to achieve statistical power and roughly equal numbers of male and female mice. All genotyping was conducted through Transnetyx automated genotyping PCR services.
In vivo seizure monitoring. Custom EEG headsets (PlasticsOne) were implanted in 5-week-old Scn8aW/+-PV mice and 6- to 8-week-old Scn8aD/+ mice using standard surgical techniques as previously described (85). Anesthesia was induced with 5% and maintained with 0.5%–3% isoflurane. Adequacy of anesthesia was assessed by lack of toe-pinch reflex. A midline skin incision was made over the skull and connective tissue was removed. Burr holes were made at the lateral/anterior end of the left and right parietal bones to place EEG leads and at the interparietal bone for ground electrodes. EEG leads were placed bilaterally in the cortex or unilaterally placed in the cortex and superior colliculus using a twist. A headset was attached to the skull with dental acrylic (Jet Acrylic; Lang Dental). Mice received postoperative analgesia with ketoprofen (5 mg/kg, i.p.) and 0.9% saline (0.5 mL i.p.) and were allowed to recover a minimum of 2–5 days before seizure-monitoring experiments.
Mice were then individually housed in custom-fabricated chambers and monitored for the duration of the experiment. The headsets were attached to a custom low-torque swivel cable, allowing mice to move freely in the chamber. EEG signals were amplified at 2,000× original magnification, and bandpass-filtered between 0.3 and 100 Hz, with an analog amplifier (Neurodata model 12, Grass Instruments). Biosignals were digitized with a Powerlab 16/35 and recorded using LabChart 7 software at 1 kS/s. Video acquisition was performed by multiplexing 4 miniature night vision–enabled cameras and then digitizing the video feed with a Dazzle Video Capture Device and recording at 30 fps with LabChart 7 software in tandem with biosignals.
Immunohistochemistry. Brain tissue for immunohistochemistry was processed as previously described (11, 86). Mice were anesthetized and transcardially perfused with 10 mL PBS followed by 10 mL 4% paraformaldehyde (PFA). Brains were immersed in 4% PFA overnight at 4°C and stored in PBS. Coronal brain sections, 30 μm, were obtained using a cryostat. Sections were incubated with mouse anti-PV (MilliporeSigma, MAB1572) diluted in 2% goat serum (Jackson ImmunoResearch Laboratories) with 0.1% Triton X-100 (MilliporeSigma) at a concentration of 1:500 in Dulbecco’s PBS. The secondary antibody, goat anti-mouse Alexa Fluor 488 (Invitrogen, A-11029), was diluted 1:1,000 in goat serum (2%) and Triton X-100 (0.1%) in Dulbecco’s PBS. Sections were stained free-floating in primary antibody on a shaker at 4°C overnight and with secondary antibody for 1 hour at room temperature the following day. Tissues were counterstained with NucBlue Fixed Cell ReadyProbes Reagent (DAPI) (Thermo Fisher Scientific, catalog R37606) included in the secondary antibody solution. Tissues were mounted on slides using AquaMount (Polysciences).
Brain slice preparation. Preparation of acute brain slices for patch-clamp electrophysiology experiments was modified from standard protocols previously described (10, 11, 30). Mice were anesthetized with isoflurane and decapitated. The brains were rapidly removed and kept in chilled artificial cerebrospinal fluid (ACSF) (0°C) containing (in mM): 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 2 CaCl2, 1 MgCl2, 0.5 l-ascorbic acid, 10 glucose, 25 NaHCO3, and 2 Na-pyruvate. For dual-cell patch-clamp experiments, the slicing solution was modified to contain (in mM): 93 N-Methyl-d-glucamine, 2.5 KCl, 1.25 NaH2PO4, 20 HEPES, 5 l-ascorbic acid (sodium salt), 2 thiourea, 3 sodium pyruvate, 0.5 CaCl2, 10 MgSO4, 25 d-glucose, and 12 N-acetyl-l-cysteine, 30 NaHCO3, with pH adjusted to 7.2–7.4 using HCl (osmolarity 310 mOsm). Slices were continuously oxygenated with 95% O2 and 5% CO2 throughout the preparation. Coronal or horizontal brain sections, 300 μm, were prepared using a Leica Microsystems VT1200 vibratome. Slices were collected and placed in ACSF warmed to 37°C for about 30 minutes and then kept at room temperature for up to 6 hours.
Electrophysiology recordings. Brain slices were placed in a chamber superfused (~2 mL/min) with continuously oxygenated recording solution warmed to 32 ± 1°C. In Scn8aD/+ tdTomato PV-Cre, Scn8aW/+ tdTomato PV-Cre, or WT tdTomato PV-Cre mice, cortical layer IV/V PV interneurons were identified as red fluorescent cells, and pyramidal neurons were identified based on morphology and absence of fluorescence via video microscopy using a Carl Zeiss Axioscope microscope. Whole-cell recordings were performed using a Multiclamp 700B amplifier with signals digitized by a Digidata 1322A digitizer. Currents were amplified, lowpass-filtered at 2 kHz, and sampled at 100 kHz. Borosilicate electrodes were fabricated using a Brown-Flaming puller (model P1000, Sutter Instruments) to have pipette resistances between 1.5 and 3.5 MΩ. All patch-clamp electrophysiology data were analyzed using custom MATLAB scripts or ClampFit 10.7.
Intrinsic excitability recordings. Current-clamp recordings of neuronal excitability were collected in ACSF solution identical to that used for preparation of brain slices. The internal solution contained the following (in mM): 120 K-gluconate, 10 NaCl, 2 MgCl2, 0.5 K2EGTA, 10 HEPES, 4 Na2ATP, and 0.3 NaGTP, pH 7.2 (osmolarity 290 mOsm). Intrinsic excitability was assessed using methods adapted from those previously described (10, 11). Briefly, resting membrane potential was manually recorded from the neuron at rest. Current ramps from 0 to 400 pA over 4 seconds were used to calculate passive membrane and AP properties, including threshold, upstroke and downstroke velocity, which are the maximum and minimum slopes on the AP, respectively; amplitude, which was defined as the voltage range between AP peak and threshold; APD50, which is the duration of the AP at the midpoint between threshold and peak; input resistance, which was calculated using a –20 pA pulse in current-clamp recordings; and rheobase, which was defined as the maximum amount of depolarizing current that could be injected into neurons before eliciting an AP. AP frequency–current relationships were determined using 1-second current injections from –140 to 1,200 pA. Spikes were only counted if AP overshoot was >0 mV and amplitude was >20 mV. The threshold for depolarization block was operationally defined as the current injection step that elicited the maximum number of APs (i.e., subsequent current injection steps of greater magnitude resulted in fewer APs because of entry into depolarization block).
Sodium current recordings. INaP and INaR were recorded in the whole-cell patch clamp configuration in-slice, whereas transient sodium current was recorded in the outside-out configuration. The internal solution for all voltage-gated sodium channel recordings contained the following (in mM): 140 CsF, 2 MgCl2, 1 EGTA, 10 HEPES, 4 Na2ATP, and 0.3 NaGTP with the pH adjusted to 7.3 and osmolality to 300 mOsm. The external solution for recording persistent and resurgent sodium currents has been previously described (87, 88) and contained (in mM): 100 NaCl, 40 TEACl, 10 HEPES, 3.5 KCl, 2 CaCl2, 2 MgCl2, 0.2 CdCl2, 4 of 4-aminopyridine, and 25 d-glucose. Outside-out recordings of transient sodium current were collected in ACSF as the external solution. Steady-state INaPs were elicited using a voltage ramp (20 mV/s) from –80 to –20 mV. To record resurgent sodium currents (INaR), PV interneurons were held at –100 mV, depolarized to 30 mV for 20 ms, and then stepped to voltages between −100 mV and 0 mV for 40 ms. After collecting recordings at baseline, protocols were repeated in the presence of 500 nM TTX (Alomone Labs) to completely block INaP and INaR. Traces obtained in the presence of TTX were subtracted from those obtained in its absence. The V1/2 of INaP was calculated as previously described (88). Patch clamp recordings in the outside-out configuration were collected using a protocol modified from an approach previously described (10, 11). Voltage-dependent activation and steady-state inactivation parameters were recorded using voltage protocols previously described (11). For all sodium current recordings, we waited 2 minutes after achieving whole-cell configuration to account for initial shifts in the voltage dependence of activation.
IPSC recordings. Patch-clamp recordings of IPSCs generated in PCs were performed using the same ACSF external solution and an internal solution containing (in mM): 70 K-Gluconate, 70 KCl, 10 HEPES, 1 EGTA, 2 MgCl2, 4 MgATP, and 0.3 Na3GTP, with the pH adjusted to 7.2–7.4 and osmolarity to 290 mOsm. Pyramidal cells were held at –70 mV and a 1-minute gap-free recording was performed in the voltage-clamp configuration to assess spontaneous IPSC frequencies before bath application of 500 nM TTX to record miniature IPSCs. After recording spontaneous and miniature IPSCs, 1 μM gabazine was bath applied to block currents and ensure that only inhibitory events were recorded.
Dual-cell synaptic connection recordings. uIPSCs were obtained via 2 simultaneous patch-clamp recordings from synaptically connected neurons located within 50 μm of one another in the somatosensory cortex of a horizontal slice. A 2 ms pulse at 1,000 pA elicited APs in the presynaptic neuron at 1, 5, 10, 20, 40, 80, and 120 Hz. The internal solution was modified to contain (in mM): 65 K-gluconate, 65 KCl, 2 MgCl2, 10 HEPES, 0.5 EGTA, 10 phosphocreatine-Tris2, 4 MgATP, and 0.3 NaGTP, with pH adjusted to 7.2–7.4 using KOH (osmolarity 290 mOsm) (23). PPR was calculated as the amplitude of the second IPSC divided by the amplitude of the first IPSC. PPR was not calculated for trials in which the first and/or second IPSC event was a failure. uIPSC failures were identified by the absence of a transient current greater than 5 pA occurring within 5 ms of the presynaptic AP. Synaptically connected pairs were not used for analysis if resting membrane potential shifted more than 10 mV during recording.
Statistics. Analysis of electrophysiological data was performed in a blinded manner. All statistical comparisons were made using the appropriate test in GraphPad Prism 9. Categorical data were analyzed using Fisher’s exact test. For membrane and AP properties, spontaneous firing frequency, depolarization block threshold, peak sodium currents, half-maximal voltages, IPSC frequency and amplitude, and synaptic uIPSC properties, mouse genotypes were compared by 1-way ANOVA followed by Dunnett’s multiple comparisons test when the data were normally distributed with equal variances, by Brown-Forsythe ANOVA with Dunnett’s multiple comparisons test when the data were normally distributed with unequal variances, and by the nonparametric Kruskal–Wallis test followed by Dunn’s multiple comparisons test when the data were not normally distributed. Data were assessed for normality using the Shapiro-Wilk test. Bartlett’s test with P = 0.05 was used to assess equal variance. Data were tested for outliers using the ROUT or Grubbs’s method to identify outliers, and statistical outliers were not included in data analysis. A 2-way ANOVA followed by Tukey’s test for multiple comparisons was used to compare groups in experiments in which repetitive measures were made from a single cell over various voltage commands or current injections. Cumulative distribution (survival) plots were analyzed by the log-rank Mantel-Cox test. Data are presented as individual data points and/or mean ± SEM. Exact n and P values are reported in figure legends.
Study approval. Animal experiments were performed in compliance with animal care guidelines issued by the NIH and Animal Care and Use Committee at the University of Virginia (protocol approval no. 3308).
Data availability. Individual data values are available in the Supporting Data Values document. Supplemental material is available in the online version.
RMM, ERW, and MKP conceptualized the study. RMM, ARB, SK, JCH, PSP, MSY, TCJD, CMR, SRV, and ERW acquired data for the study. RMM, ARB, SK, and MSY analyzed data for the study. RMM compiled all figures for the manuscript. RMM and MKP drafted the manuscript. RMM, ERW, and MKP edited the manuscript.
This work was funded by NIH R01 NS103090, NIH R01 NS122834, and NIH R01 NS120702 to MKP; diversity supplement NIH R01 NS122834-S1 to MKP and RMM; a Virginia Brain Institute Graduate Fellowship to RMM and CMR; and NIH F31 NS134264 to RMM.
Address correspondence to: Manoj K. Patel, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, Virginia 22908, USA. Email: mkp5u@uvahealth.org.
Conflict of interest: The authors have declared that no conflict of interest exists.
Copyright: © 2024, Miralles et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
Reference information: JCI Insight. 2024;9(20):e181005.https://doi.org/10.1172/jci.insight.181005.